Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Epithelial Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02307240
What this trial is testing

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Who this might be right for
Triple-Negative Breast CancerHigh-grade Serous Ovarian CancerSolid Tumors+1 more
Curis, Inc. 43
Early research (Phase 1)Ended earlyNCT04718376
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 56
Not applicableStudy completedNCT01869400
What this trial is testing

An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
PharmaMar, Spain 83
Testing effectiveness (Phase 2)Looking for participantsNCT05080556
What this trial is testing

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Who this might be right for
Ovarian CancerRelapsed Ovarian CancerFallopian Tube Cancer+4 more
University College, London 80
Early research (Phase 1)Active Not RecruitingNCT04503278
What this trial is testing

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

Who this might be right for
Solid Tumor
BioNTech Cell & Gene Therapies GmbH 214
Testing effectiveness (Phase 2)Study completedNCT00453310
What this trial is testing

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTeratoma+1 more
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT04718675
What this trial is testing

KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Who this might be right for
Relapsed Solid TumorsRefractory Solid TumorsNon-Hodgkin Lymphoma+2 more
Kronos Bio 135
Testing effectiveness (Phase 2)Study completedNCT00523380
What this trial is testing

Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer

Who this might be right for
CancerOvarian Cancer
Novo Nordisk A/S 10
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01482715
What this trial is testing

Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+1 more
pharmaand GmbH 136
Early research (Phase 1)Looking for participantsNCT07690189
What this trial is testing

Study of NTB-928 in R/R OC

Who this might be right for
Relapsed/Refractory Ovarian Carcinoma
TeneoSeven, Inc. 90
Large-scale testing (Phase 3)UnknownNCT00108745
What this trial is testing

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+24 more
GOG Foundation 1,157
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Ended earlyNCT04826198
What this trial is testing

Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months

Who this might be right for
Ovarian Cancer
Gustave Roussy, Cancer Campus, Grand Paris 13
Post-approval studies (Phase 4)Not Yet RecruitingNCT06887933
What this trial is testing

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
GlaxoSmithKline 67
Large-scale testing (Phase 3)Looking for participantsNCT06828354
What this trial is testing

SHR-A1811 in Subjects With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 300
Large-scale testing (Phase 3)UnknownNCT00532194
What this trial is testing

An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Medical Research Council 486
Testing effectiveness (Phase 2)Ended earlyNCT03323398
What this trial is testing

Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies

Who this might be right for
Relapsed/Refractory Solid Tumor Malignancies or LymphomaOvarian Cancer
ModernaTX, Inc. 79
Large-scale testing (Phase 3)Study completedNCT00189553
What this trial is testing

Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse

Who this might be right for
Ovarian CancerFallopian Tube Cancer
ARCAGY/ GINECO GROUP 976
Testing effectiveness (Phase 2)WithdrawnNCT01766622
What this trial is testing

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

Who this might be right for
Ovarian NeoplasmsOvarian CancerFallopian Tube Neoplasms+1 more
National Institutes of Health Clinical Center (CC)
Next Page